To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Catalent to buy GPP-backed Belgian cell therapy firm for $315 mln
Catalent has agreed to acquire MaSTherCell Global, which is backed by Great Point Partners, SFPI-FPIM and Orgenesis Inc, for $315 million in cash.
